Description: BioGaia AB (publ), a healthcare company, provides probiotic products worldwide. The company operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment provides packaging solutions. It sells its products through distribution partners or through its own distribution channels. BioGaia AB (publ) was incorrporated in 1990 and is based in Stockholm, Sweden.
Home Page: www.biogaia.com
Kungsbroplan 3
Stockholm,
112 27
Sweden
Phone:
46 8 55 52 93 00
Officers
| Name | Title |
|---|---|
| Mr. Peter Rothschild M.Sc. Econ., MBA | Founder & Chairman |
| Ms. Theresa P. Agnew | CEO & President |
| Mr. Alexander Kotsinas M.Sc. (Eng.). | Executive VP & CFO |
| Ludvig Milesson | Chief Operating Officer |
| Mr. Gianfranco Grompone | Chief Scientific Officer and VP of Research & Development |
| Ms. Caroline Mofors | Chief Legal Officer |
| Ms. Linda Hagglund | Vice President of Marketing |
| Ms. Angelika Kjelldorff | Chief HR Officer |
| Sebastian Heimfors | VP & Chief Commercial Officer |
| Jonathan Gromark | Sustainability Manager |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 31.1897 |
| Price-to-Book MRQ: | 6.492 |
| Price-to-Sales TTM: | 0.6818 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 222 |